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Altered network properties in C9ORF72
repeat expansion cortical neurons are due
to synaptic dysfunction
Emma M. Perkins1,2,3†, Karen Burr1,2,4†, Poulomi Banerjee2,4, Arpan R. Mehta1,2,4, Owen Dando3,4,5,
Bhuvaneish T. Selvaraj1,2,4, Daumante Suminaite3, Jyoti Nanda1,2,4, Christopher M. Henstridge1,6,
Thomas H. Gillingwater1,3, Giles E. Hardingham3,4,5, David J. A. Wyllie3,5,7, Siddharthan Chandran1,2,4,5,7* and
Matthew R. Livesey1,3,5,8*
Abstract
Background: Physiological disturbances in cortical network excitability and plasticity are established and widespread
in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients, including those harbouring the
C9ORF72 repeat expansion (C9ORF72RE) mutation – the most common genetic impairment causal to ALS and FTD.
Noting that perturbations in cortical function are evidenced pre-symptomatically, and that the cortex is associated with
widespread pathology, cortical dysfunction is thought to be an early driver of neurodegenerative disease progression.
However, our understanding of how altered network function manifests at the cellular and molecular level is not clear.
Methods: To address this we have generated cortical neurons from patient-derived iPSCs harbouring C9ORF72RE
mutations, as well as from their isogenic expansion-corrected controls. We have established a model of network
activity in these neurons using multi-electrode array electrophysiology. We have then mechanistically examined the
physiological processes underpinning network dysfunction using a combination of patch-clamp electrophysiology,
immunocytochemistry, pharmacology and transcriptomic profiling.
Results: We find that C9ORF72RE causes elevated network burst activity, associated with enhanced synaptic input, yet
lower burst duration, attributable to impaired pre-synaptic vesicle dynamics. We also show that the C9ORF72RE is
associated with impaired synaptic plasticity. Moreover, RNA-seq analysis revealed dysregulated molecular pathways
impacting on synaptic function. All molecular, cellular and network deficits are rescued by CRISPR/Cas9 correction of
C9ORF72RE. Our study provides a mechanistic view of the early dysregulated processes that underpin cortical network
dysfunction in ALS-FTD.
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Conclusion: These findings suggest synaptic pathophysiology is widespread in ALS-FTD and has an early and
fundamental role in driving altered network function that is thought to contribute to neurodegenerative processes in
these patients. The overall importance is the identification of previously unidentified defects in pre and postsynaptic
compartments affecting synaptic plasticity, synaptic vesicle stores, and network propagation, which directly impact
upon cortical function.
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Background
C9ORF72 hexanucleotide repeat expansion (C9ORF72RE)
is the most common mutation found within the ALS-FTD
spectrum, giving rise to incurable, rapidly progressive and
fatal disease pathologically characterised by degeneration of
cortical neurons and upper and spinal motor neurons.
Cortical circuit dysfunction is a consistent and prominent
finding in C9ORF72RE patients [5, 42, 50, 62]. Altered
cortical network excitability is considered to be an early
pathogenic driver of ALS and FTD contributing directly to
excitotoxicity-mediated neurodegeneration of upper motor
neurons and cortical neurons [21, 22, 36, 37, 58–60, 62].
Furthermore, clinical neurophysiological studies of
C9ORF72RE patients have demonstrated notable impair-
ments in cortical network plasticity at the pre-symptomatic
stage [5]. For many progressive neurodegenerative diseases,
including ALS-FTD, functional impairments in plasticity
are thought to manifest early in disease progression, being
representative of altered synaptic homeostasis that precede
and potentially cause neuronal dysfunction and/or loss, and
lead to cognitive impairments [38, 55, 56].
Our current mechanistic understanding of potential
sources of altered cortical network excitability in ALS-
FTD is derived largely from mutant murine models
(SOD1 and TDP-43 mutations) of ALS and ALS-FTD
[17, 30, 45, 48, 65], but does not extend to provide a
physiological basis for altered network excitability. Similarly,
our understanding of the potential synaptic plasticity dysreg-
ulation that may occur in ALS-FTD has come from studies
that use ex vivo brain slice preparations from rodent models
of rare genetic mutations [24, 54]. Functional impairments
in synaptic plasticity in ALS-FTD have yet to be examined
in a human-based model system. Identified physiological
disturbances in ALS motor neurons [55] also may provide
insights into cortical neuron pathophysiology though this
must remain highly tentative given that diverging potential
pathophysiological mechanisms in C9ORF72RE cortical and
spinal neurons are established [52]. Despite its proposed
pathogenicity and early prominence, cortical dysfunction in
ALS-FTD remains poorly defined at both the synaptic and
network level.
To address this, we have used human induced pluripo-
tent stem cell (iPSC) derived cortical neurons from patients
harbouring C9ORF72RE mutations, combined with gene-
edited isogenic paired lines [52], to interrogate the conse-
quence of C9ORF72RE on cortical neuronal physiology. In
view of dysregulation of glutamate homeostasis being a
major hypothesis underlying ALS-FTD [9, 55], we have ex-
amined physiological perturbations in iPSC-derived gluta-
matergic cortical neurons. We determine that C9ORF72RE
neurons display altered network properties that are under-
pinned by synaptic dysfunction, but not altered intrinsic
cellular excitability, and display impairments in synaptic
plasticity. Our transcriptomic analysis highlights dysregu-
lated molecular pathways in accordance with physiological
observations. Our observations are notably different from
those previously reported for C9ORF72RE motor neurons
and provide evidence of cortical-specific pathophysiology
that may contribute to cortical dysfunction in ALS-FTD.
Methods
iPSCs
Dermal fibroblasts from patient and control individuals
were obtained under full Ethical/Institutional Review
Board approval at the University of Edinburgh. Fibroblasts
were reprogrammed to iPSCs by either Sendai virus or
retrovirus expressing OCT4, SOX2, C-MYC, and KLF4.
iPSCs were maintained in Matrigel (BD Biosciences)-
coated plastic dishes in E8 medium (Life Technologies) at
37 °C and 5% CO2. Lines were derived from three patients
harbouring repeat expansions in the C9ORF72 gene [52]
and a healthy individual with no known association with
neurodegenerative disease.
Anterior precursor (aNPC) derivation
Human iPSCs were maintained on Matrigel (Corning),
with Advanced DMEM/F12, 20% Knockout Serum
Replacement, FGF-2 (10 ng/mL), L-glutamine (1mM), 2-
mercaptoethanol (100mM) and 1% penicillin/streptomycin
(P/S). All media were obtained from Life Technologies.
Human iPSCs were neurally converted in suspension
in chemically defined medium as described [6]. The media
was changed to base media (Advanced-DMEM/F12, 1% P/
S, 1% Glutamax, 1% N-2), 0.5% B-27, FGF-2 (2.5 ng/mL)
upon observation of radially organised structures in neuro-
spheres (10–21 days) and plated on Laminin (Sigma) coated
tissue culture plates (Nunc) a week later. Neural rosettes
were mechanically isolated, dissociated with Accutase
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(Sigma) and 20-40 k cells were plated in one Laminin-
coated well of a 6-well plate in proliferation media (Base
media, 0.2% B-27, 10 ng/mL FGF-2). aNPCs were grown to
high density before passaging 1:2 with Accutase on laminin
coated plates until passage 5–6 and maintained on 1:100
Reduced-growth factor Matrigel-coated plates thereafter or
cryopreserved as described [6].
Differentiation of aNPCs into cortical neuronal cultures
aNPCs were plated in default media on poly-ornithine
(Sigma), laminin (Sigma), fibronectin (Sigma) and
Matrigel-coated coverslips in which primary mouse astro-
cytes have been propagated. Primary mouse astrocytes
were prepared as previously described [26]. Density of
astrocytes was 100,000 per 13mm coverslip at least 48 h
prior to plating aNPCs. Cultures were fed twice a week.
Default medium was supplemented with forskolin (10 μM,
Tocris) from days 7–21 after aNPC platedown (200,000
per coverslip) and with BDNF and GDNF (both 5 ng/mL)
from day 28 onwards. Coverslips were then processed
fixed and stained as previously described [6]. Multi-
electrode arrays were first coated with poly-D-lysine then
the laminin, fibronectin and Matrigel-coating was applied
to the region containing the electrode arrays (60MEA200/
30iR-Ti, Multi Channel Systems). aNPCs were plated to
the coating spot and left for 2 h to adhere. Array wells
were then flooded with default media containing sus-
pended DIV14 mouse astrocytes.
Immunohistochemistry
Five–six weeks old cultures on glass coverslips were
fixed in 4% PFA at room temperature (RT) for 20 min.
They were permeabilised with 0.1% tritonX-100, blocked
with 6% goat serum and stained with primary antibodies
against βIII-tubulin (dilution 1:500, Sigma), human nu-
clei (dilution 1:200, Millipore), nestin (dilution 1:200,
Millipore), GFAP (1:400, Sigma), synapsin-1 (dilution 1:
500, Sigma) and PSD-95 (dilution 1:250; Neuromab)
sequentially for 2 h at RT. These were then probed with
appropriate secondary antibodies and mounted with
FluorSave and imaged in Zeiss LSM Z10 confocal micro-
scope using 63X objective. For synaptic density analysis,
5 fields of 20 μm region across 3 coverslips were analysed
for the co-localised puncta of synapsin-1 and PSD-95
using colocalization plugin in ImageJ.
RNA extraction, RNA sequencing and transcriptomic
analysis
Total RNA was extracted from cortical neurons from 2
independent isogenic corrected paired cell lines at day
35 post platedown using RNeasy Mini kit (Qiagen), ac-
cording to the manufacturer’s instructions. RNA samples
were assessed for concentration (NanoDrop ND-100
Spectrometer, NanoDrop Technologies) and quality
(Agilent 2200 Tapestation, Agilent Technologies) before
library preparation. Library preparation and sequencing
were carried out by Edinburgh Genomics (Edinburgh,
UK). For each sample, cDNA was converted to a sequen-
cing library using the TruSeq stranded mRNA-seq
library. Barcoded libraries were pooled and sequenced
on an Illumina HiSeq 4000 using 75 base paired-end
reads to generate at least 111 million raw reads per
sample. The reads were mapped to the primary assembly
of the human (hg38) reference genome contained in
Ensembl release 90 [12]. Alignment was performed with
STAR, version 2.5.3a [16]. Tables of per-gene read
counts were generated from the mapped reads with fea-
tureCounts version 1.5.2 [33]. Differential gene expres-
sion analysis, using DESeq2 version 1.18.1, specifically
examined the intersection in commonly and concor-
dantly differentially expressed genes between the two
mutant-isogene pairs, using a false discovery rate of 20%,
achieved by setting a Benjamini-Hochberg corrected p-
value threshold of 0.2 (genes with an average FPKM < 1
were disregarded). Gene ontology (GO) analysis was
performed on all the differentially expressed genes to
identify putatively altered pathways or processes using
topGO version 2.30.1 [1]. RNA-seq data are available
upon request to the corresponding authors.
Morphology
Cortical NPCs were sparsely transduced with lentivirus
expressing GFP in order to label individual cells for ana-
lysis (ca. 1 viral particle to 10 cells). Following labelling
with GFP, NPCs were differentiated as mentioned above
and immunohistochemistry was performed against GFP
and β3-tubulin. These were then probed with appropri-
ate secondary antibodies and mounted with FluorSave
and imaged in Zeiss LSM Z10 confocal microscope
using 20X objective. Total neurite length (sum of all the
processes) in the GFP channel was manually traced
using ImageJ.
Multi-electrode array (MEA) electrophysiology
Extracellular recordings from 59 channels per array were
acquired at 37 °C in the culture media using a
Multi Channel Systems MEA system at a sampling rate
of 20 kHz. Data was analysed using the Multichannel
Systems software and in-house custom Matlab scripts.
Patch-clamp electrophysiology
For other electrophysiological experiments, whole-cell
patch-clamp recordings were performed as described [6, 34]
using electrodes filled with (in mM): 155 K-gluconate, 2
MgCl2, 10 Na-HEPES, 10 Na-PiCreatine, 2Mg2-ATP, and
0.3 Na3-GTP, pH 7.3, 300mOsm. For spontaneous action
potential activity, cells were typically bathed in an extracellu-
lar recording comprising (in mM): 152 NaCl, 2.8 KCl, 10
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HEPES, 2 CaCl2, 10 glucose, pH 7.3, 320–330mOsm. For
mEPSC recordings, the extracellular solution was supple-
mented with TTX (1 nM), picrotoxin (50 μM) and MgCl2
(1.5mM). For intrinsic membrane and excitability proper-
ties, the extracellular solution was supplemented with
CNQX (5 μM) and D-APV (50 μM). Recordings were per-
formed at room temperature (20-23 °C). Current and voltage
measurements were typically low-pass filtered online at 2
kHz, digitized at 10 kHz and recorded to computer using
the WinEDR V2 7.6 Electrophysiology Data Recorder (J.
Dempster, Department of Physiology and Pharmacology,
University of Strathclyde, UK; www.strath.ac.uk/
Departments/PhysPharm/). Series resistance compensation
was applied up to 75%. Recordings were omitted from
analysis if the series resistance changed by more than 20%
during the experiment, or if they exceeded 20MΩ.
Burst analysis
Burst detection for both single cells and MEAs were per-
formed using custom-written Matlab scripts. For patch-
clamp recordings action potentials were identified using
threshold detection (routinely set at − 10 mV) and bursts
were defined as groups of action potentials with a mini-
mum inter burst period set as log10 of the intra spike
interval. For each MEA, 4–10 active channels were se-
lected for further analysis. Bursts were identified as ac-
tivity 2–5 times the standard deviation of the baseline
(as determined by the signal-to-noise ratio) with a mini-
mum quiet period set to define separate bursts. This was
routinely set to 5 s given the lowest observed inter burst
period was 9.6 s. The spike threshold was variable, but
consistent between each of our isogenic and C9 pairs for
each experiment and optimal to detect as many, but
variable, number of channels with robust activity. On all
MEAs there were both active and inactive channels
(likely due to some electrodes not having active cells
close enough) but all the active channels showed the
same pattern of activity with low standard deviation in
the burst start times across channels ranging from 0.10
to 0.78 s, indicating a synchronous network across the
area of the MEA electrodes.
mEPSC analysis
mEPSC recordings were analysed offline using the
WinEDR software stated above. A dead time window of
10 ms was set and individual mEPSCs were detected
using an algorithm that selected for mEPSCs below a −
4 to – 6 pA amplitude threshold and greater than 1 ms
in duration. mEPSCs that had a monotonic rising phase
with a 10–90 rise time of lower than 6ms and a Ƭ-decay
with a decay time constant of lower than 25ms were se-
lected for analysis. Recordings were then visually
inspected for validity. For mEPSC analysis (Fig. 2c), data
were obtained from at least 2-min recordings and
neurons that displayed mEPSC frequencies under 0.05
Hz were omitted from the analysis. For sucrose experi-
ments, baseline mEPSC properties were determined
from a 2-min stretch of mEPSC activity of at least 0.05
Hz. The transient phase was determined from the onset
of sucrose application to the transition of mEPSC activ-
ity to steady-state activity. Steady-state data were deter-
mined from at least a 30 s stretch of mEPSC activity in
continued presence of sucrose.
Statistical analysis
Statistical analysis was performed using GraphPad Prism
software. Data are represented as mean ± s.e.m. *p < 0.05,
**p < 0.01, ***p < 0.001. The number of experimental rep-
licates (for MEA recordings, this indicates number of
plates; for patch-clamp recordings this indicates number
of cells) is denoted as n and N represents the number of
independent de novo preparations of batches from
which n is obtained. Data were initially determined to be
parametric or non-parametric before applying either
one-way ANOVA with Bonferroni’s multiple comparisons
test or unpaired t-tests or Welch’s t-test, as appropriate.
Results
C9ORF72RE-derived cortical neurons display network
dysfunction
iPSCs from three patients harbouring C9ORF72RE muta-
tions (C9–1,2,3), three paired isogenic control lines (C9-
Δ1,2,3) in which the C9ORF72RE mutation had been se-
lectively excised by CRISPR/Cas9-mediated gene-editing
[52], and an unrelated healthy individual (Con) were
used to generate cultures of excitatory cortical neurons
using an established protocol [6, 52]. Cortical neurons
were maintained in co-culture with primary mouse as-
trocytes in order to promote neuronal maturation [35]
and experiments were performed at 4-to-6 weeks post
differentiation. Cultures efficiently differentiated into
enriched populations of neurons by this time point
(Supplementary Figure 1) and presented a marker profile
consistent with a glutamatergic cortical neuron identity
(Supplementary Figure 2).
To examine network dysfunction in C9ORF72RE excita-
tory cortical neurons we initially used a multi-electrode
array (MEA) recording platform. C9ORF72RE excitatory
cortical neurons displayed an increase in the rate of burst
firing (reduced network burst duration and inter-burst
lengths versus healthy and isogenic controls) (Fig. 1a). Al-
though shorter inter-burst lengths are typically associated
with increased glutamate-mediated excitatory network ac-
tivity, the reduced network burst duration in C9ORF72RE
cortical neurons (Fig. 1a) is inconsistent with this [3, 43].
Intra-burst spike frequency was comparable across all
lines (Fig. 1a) suggesting that intrinsic excitability is
unaffected. We then examined whether spontaneous
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network activity was maintained at the single-cell level
using whole-cell patch-clamp recording. Burst activity
from C9ORF72RE neurons also showed a similarly reduced
inter-burst length and burst duration and no change in
intra-burst spike frequency versus controls (Fig. 1b).
Spontaneous burst firing was blocked by CNQX and was
not affected by bicuculline consistent with an enriched
population of excitatory glutamatergic neurons and the
absence of GABA-ergic interneurons (Supplementary
Figure 3 [6, 34, 52];). Our data show that network activity
is altered in C9ORF72RE cortical neurons.
A possible determinant of altered network excitability
may be due to differences in the intrinsic membrane prop-
erties and intrinsic capacity of C9ORF72RE cortical neu-
rons to fire and maintain action potentials. Previously, our
work and others has shown such properties to be altered
in C9ORF72RE motor neurons [14, 49, 61, 66], but remains
to be described in the context of C9ORF72RE cortical neu-
rons. Our network analysis suggests no difference in in-
trinsic excitability, so we therefore directly examined these
intrinsic properties by performing whole-cell current-
clamp recordings in the presence of blockers of fast synap-
tic transmission. Our measurements of intrinsic mem-
brane properties (resting membrane potential, input
resistance and whole-cell capacitance) and the generation
of action potentials in response to depolarisation are com-
parable across all lines (Supplementary Figure 5). These
data are collectively consistent with intrinsic membrane
and excitability properties not being a determinant of al-
tered network activity in C9ORF72RE neurons.
Fig. 1 Altered network function in C9ORF72RE-derived cortical neurons. a Left, Representative MEA recordings from control (blue), C9ORF72RE-
(black) and respective C9ORF72RE gene-edited- (red) derived neuronal cultures each showing traces from four electrodes from single arrays. Note
the difference in the network burst properties in C9ORF72RE-derived cultures. Scale bar, 50 μV, 30 s. Right, Mean (± s.e.m.) data for control (Con),
C9ORF72RE- (C9) and respective C9ORF72RE gene-edited- (C9-Δ) derived neurons for interburst and network burst lengths (Con, N = 9; C9, N = 10;
C9-Δ, N = 9) and intra-network burst spiking frequencies (Con, N = 7; C9, N = 6; C9-Δ, N = 8). Data are pooled for C9 and C9-Δ – individual pair
comparisons are presented in Supplementary Figure 4A. b Left, Representative current-clamp recordings from control, C9ORF72RE- and respective
C9ORF72RE gene-edited-derived neurons (cells were held at − 74mV; scale bar, 20 mV, 30 s). Right, Mean (± s.e.m.) data for control (Con),
C9ORF72RE- (C9) and respective C9ORF72RE gene-edited- (C9-Δ) derived neurons for interburst lengths, burst lengths and intraburst spiking
frequencies (Con, n = 10, N = 4; C9, n = 16, N = 4; C9-Δ, n = 13, N = 4). Data are pooled for C9 and C9-Δ – individual pair comparisons are
presented in Supplementary Figure 4B. Note that differences in burst properties between MEA and patch-clamp experiments are likely to reflect
differing resting membrane potentials and recording temperatures at which experiments are conducted and/or the alternate plating order of
neurons and astrocytes for each respective approach. Significance determined by one-way ANOVA with Bonferroni’s post hoc test
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C9ORF72RE-derived cortical neurons have increased
synaptic input
To determine whether the altered network activity in
C9ORF72RE-derived cortical neurons was of synaptic
origin we undertook quantification of the co-localisation
of pre- (synapsin-1) and post-synaptic (PSD-95) markers
and observed an increase in synaptic densities on
C9ORF72RE versus control neurons (Fig. 2a, Supplemen-
tary Figure 6A). Increased synaptic density may reflect
an increase in neuronal morphology and therefore we
examined the neurite length in our cultures
(Supplementary Figure 6B, C). However, consistent with
our whole-cell capacitance measurements, our data did
not reveal any morphological changes that could ac-
count for the large change in synaptic density in
C9ORF72RE neurons. Consistent with these data we also
found an increase in the frequency of mini excitatory
postsynaptic currents (mEPSCs) in C9ORF72RE neurons
compared to isogenic controls and healthy volunteer-
derived neurons (Fig. 2c, d, Supplementary Figure 7).
AMPAR-mediated mEPSC amplitudes and kinetics (rise-
times and decay-times), and further the expression of
AMPA receptor subunits, were not changed indicating
that the properties and expression of synaptic AMPA
receptors were not altered (Fig. 2c, d, Supplementary
Figure 7). These findings indicate that C9ORF72RE
cortical neurons display increased synaptic density
resulting in elevated synaptic input.
C9ORF72RE–derived cortical neurons exhibit pre-synaptic
dysfunction
Increased pre-synaptic glutamate release could also
underlie an increased mEPSC frequency and a central
determinant of release properties and network burst
properties is the size of the vesicle readily releasable pool
(RRP) [10, 32]. The RRP size was functionally estimated
using hypertonic sucrose, an established method to
generate Ca2+-independent exocytosis of the vesicular
RRP [40, 47]. We observed sucrose-application-evoked
mEPSC activity that can be classified into an initial
transient phase (initial depletion of the RRP) and a
steady-state phase (on-going replenishment of the RRP;
Fig. 2e and Supplementary Figure 8A [40];). Given that
conventional measurements of RRP are determined by
the integral of the total evoked current and are directly
proportional to synaptic density we have examined the
fold change in mEPSC frequencies because C9ORF72RE
cortical neurons exhibit increased synaptogenesis over
control lines. A fold reduction in mEPSC frequency (Fig.
2f, Supplementary Figure 8B), but not their amplitude
(Supplementary Figure 8C), was observed in C9ORF72RE
neurons compared to control lines for both the transient
and steady-state phases. Thus, despite an observed in-
crease in mEPSC frequency during baseline recordings,
C9ORF72RE cortical neurons display a functionally
reduced RRP size that is replenished at a slower rate.
These data potentially explain the shorter network burst
durations in C9ORF72RE cortical neurons.
Physiological vesicular release is Ca2+-dependent and
thus we examined this by measuring fold changes in
mESPC frequencies before and after addition of KCl. No
differences in the fold change of mEPSC frequencies
were found between C9ORF72RE versus paired isogenic
control neurons (Supplementary Figure 9). These data
suggest that overall depolarisation-mediated Ca2+-evoked
release is equivalent in the pre-synaptic terminals of each
line. Nonetheless our data indicate that the RRP size is
impacted in C9ORF72RE cortical neurons.
Synaptic potentiation in C9ORF72RE cortical neurons is
impaired
Cortical network plasticity in C9ORF72RE patients is
impaired and suggests that this is due to perturbed
activity-dependent synaptic plasticity [5]. The activity-
dependent potentiation of AMPA receptor-mediated
mEPSCs is a central feature of classical models of synap-
tic plasticity and therefore we applied a series of de-
polarizing voltage steps to our neurons, as previously
described, that leads to a potentiation of the amplitude
of mEPSC in rodent hippocampal neurons [4, 29, 31, 63,
64]. Following this depolarisation pulse protocol (DPP),
we observed that mEPSCs in control neurons were tran-
siently potentiated by around 20% in amplitude from the
initial control period before returning close to control
levels (Supplementary Figure 10). No significant shift in
mEPSC amplitude was observed when no stimulation
was applied. Consistent with previous studies on primary
hippocampal neurons [4], we found this mEPSC potenti-
ation to be dependent upon the activation of voltage-
gated Ca2+ channels and intracellular elevations in Ca2+
as was blocked by voltage-gated Ca2+ channel antagonist,
nifedipine, and supplementation of Ca2+ chelator
BAPTA to the patch pipette, respectively (Supplementary
Figure 10E, Supplementary Figure 11A-F). In contrast, we
observed that DPP did not induce any potentiation of
mEPSC amplitudes in C9–1 and C9–2 neurons (Fig. 3a, c,
e-g). The respective isogenic C9–1Δ and C9–2Δ neurons
displayed a significant mEPSC potentiation post-DPP (Fig.
3b, d-g). The mEPSC decay time constant did not change
post-DPP with respect to baseline activity in either con-
trol, C9 or C9-Δ neurons suggesting that the composition
of AMPA receptors mediating mEPSCs is unchanged
post-DPP (Fig. 3f; Supplementary Figure 11G). These data
are therefore consistent with a C9ORF72RE-mediated
physiological disruption of mEPSC potentiation in
C9ORF72RE-derived cortical neurons in our model of syn-
aptic potentiation.
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Fig. 2 (See legend on next page.)
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RNA sequencing highlights molecular disruption at the
synapse in C9ORF72RE cortical neurons
To begin to understand the molecular changes that
underpin the observed physiological dysfunction in
C9ORF72RE cortical neurons, we next performed tran-
scriptomic analysis of cortical neurons derived from two
independent C9ORF72RE iPSCs (C9–1 & C9–2) and
their corresponding isogenic controls (C9-Δ1 & C9-Δ2).
Principal component analysis (PCA) of gene expression
showed segregation of differential gene expression
between the two mutant-isogenic pairs, though a high
degree of similarity within a mutant-isogene pair, as
expected (Fig. 4a). We therefore assessed our data set in
order to determine common dysregulated gene expres-
sion between the different lines employed (Fig. 4b,
Supplementary Table 1). Our biological process gene
ontology analyses (Fig. 4c) revealed dysregulated expres-
sion of genes involved in vesicle regulation (Gopc,
Vamp5), cell-cell adhesion (Cbln1, Pcdhgc4), negative
regulation of ion transport (Htr2a) fatty acid metabolism
and regulation of DNA-binding transcription factor ac-
tivity (Irak1, Sigirr). These novel transcriptomic data re-
veal dysregulated multiple pathways in C9ORF72RE
cortical neurons that may contribute to the observed
synaptic dysfunction.
Discussion
Increased synaptic glutamate transmission within the
cortex presents an attractive hypothesis to potentially
explain cortical network hyperexcitability present in
early symptomatic C9ORF72RE patients [42, 50, 62] and
ALS in general [22]. Our data provide a human in vitro
mechanistic exploration of physiological impairments in
C9ORF72RE patient-derived excitatory cortical neurons
that reveal that perturbed network activity is under-
pinned by functional synaptic alterations that impact
upon excitability. Furthermore, noting that ALS-FTD
patients exhibit impairments in network plasticity, we
have determined that C9ORF72RE cortical neurons
exhibit impairments in synaptic plasticity. Importantly,
the physiological alterations observed in iPSC-derived
C9ORF72RE cortical neurons are disparate from that
previously observed in iPSC-derived C9ORF72RE motor
neurons where intrinsic excitability appears to be pri-
marily affected [55]. Our data reveal that intrinsic excit-
ability is not affected in C9ORF72RE cortical neurons.
An increase in network burst frequency in C9ORF72RE
patient-derived excitatory cortical neurons is highly con-
sistent with a mechanism requiring increased excitatory
input. Our data demonstrate that C9ORF72RE cortical
neurons display an increased synaptic input as a result
of an increased synaptic density. Such findings are
broadly consistent with murine models of ALS, where
increased synaptic input of excitatory cortical neurons
are observed in pre-symptomatic mutant TDP-43 mice
([17]; but see [25]) and SODG93A mice [17, 48, 57].
Cortical neurophysiological impairments were not found
in a C9ORF72RE murine model though this model does
not display classical ALS-FTD pathology or neurodegen-
eration [44]. Our transcriptomic approach has revealed
potential causes to this increase in synaptic density.
PCDHGC4, a γ-protocadherin, negatively regulates the
function of neuroligin-1, a post-synaptic molecule that
interacts with pre-synaptic neurexin to maintain and
promote synapse structures in forebrain neurons [39].
Reduced expression of PCDHGC4 in our C9ORF72RE
cortical neurons is therefore compatible with increased
neuroligin-1 function and increased synaptic density.
Overexpression of neuroligin-1 has previously been
shown to increase excitatory synaptic activity in in vitro
cortical neurons [8]. Equivalently, CBLN1, is a pre-
synaptically expressed molecule that interacts with neur-
exins and promotes synaptogenesis [51] and is upregu-
lated in C9ORF72RE cortical neurons. Contrastingly,
CBLN1 has been reported to be downregulated in
C9ORF72RE iPSC-derived motor neurons [49]. Together,
(See figure on previous page.)
Fig. 2 Synaptic density, mEPSC properties and pre-synaptic dysfunction. a For each line, [control, C9ORF72RE- (C9) and C9ORF72RE gene-edited-
(C9-Δ) cortical neurons], low magnification images (scale bar, 20 μm) show immunostaining for βIII-tubulin (yellow, top left), synapsin-1 (red), PSD-
95 (green) and a PSD-95/synapsin-1 composite view (lower) from which the region of interest is highlighted. The region of interest is shown with
greater higher magnification image below (scale bar, 10 μm). b Mean ± s.e.m. co-localised PSD-95/synapsin-1 puncta per 20 μm of neurite length
for each line type (Control, N = 3; C9, N = 12; C9-Δ, N = 12). Data for C9 and C9-Δ are pooled from three respective C9ORF72RE- and gene-edited
pairs – individual pair comparisons are presented in Supplementary Figure 6A. Data from each de novo preparation represents a mean obtained
from four coverlips each consisting of five randomly selected image fields. c Sample traces from recordings of mEPSC events from control,
C9ORF72RE- and C9ORF72RE gene-edited-cortical neurons. Recordings were made at a holding potential of − 84mV. Scale bar; 20 pA, 10 s. mEPSCs
in all lines are mediated by Ca2+-impermeable (NASPM-insensitive) AMPA receptors (CNQX-sensitive). d Mean ± s.e.m. mEPSC frequency and
amplitude for each line (Control, n = 14, N = 3; C9, n = 52, N = 12; C9-Δ, n = 42, N = 11). Data are pooled for C9 and C9-Δ – individual pair
comparisons are presented in Supplementary Figure 7. e Sample traces from recordings of mEPSC events before and in the presence of sucrose
from control (Con), C9ORF72RE-(C9) and C9ORF72RE gene-edited (C9-Δ)-cortical neurons. The transient and steady-state phases evoked by sucrose
addition are highlighted. Note the difference in mEPSC frequency in these phases versus baseline. Scale bar, 50 pA, 5 s. f Mean ± s.e.m. fold
change in mEPSC frequency for each line for the transient (Control, n = 14, N = 3; C9, n = 28, N = 10; C9-Δ, n = 30, N = 9) and steady-state phases
(Control, n = 8, N = 2; C9, n = 23, N = 8; C9-Δ, n = 23, N = 8). Data are pooled for C9 and C9-Δ – individual pair comparisons are presented in
Supplementary Figure 8. Significance of data in the figure determined by one-way ANOVA with Bonferroni’s post hoc test
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Fig. 3 (See legend on next page.)
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these studies indicate that increased cortical glutamate-
mediated synaptic input is an early feature of ALS. Future
work will require to determine when increased synaptic
density alongside altered network excitability presents in
ALS progression in patients.
Many ALS-focused studies describing altered gluta-
matergic input have examined synaptic function without
assessing presynaptic function in detail, nor have they
examined the consequences for network activity. An in-
crease in excitatory synaptic input might be expected to
increase network burst duration in addition to burst
frequency [32]. However, our assessment of network
activity revealed a decrease in network burst duration
and appears to be consistent with a decrease in gluta-
matergic synaptic transmission. Consistent with this, our
evaluation of pre-synaptic function revealed an esti-
mated reduced size and replenishment of vesicular RRP.
Importantly, a reduced RRP size and replenishment rate
has been previously shown to generate early burst ter-
mination to shorten burst duration [10, 32]. This pro-
vides the most parsimonious explanation of the observed
shorter network burst duration in C9ORF72RE cortical
neurons. A disruption in the vesicular RRP suggests
mechanisms in which synaptic vesicular trafficking are
impaired. Noting that C9ORF72 is detected in pre-synaptic
terminals, our data resonate with previous studies
highlighting the role of C9ORF72 protein in vesicular traf-
ficking within the trans-Golgi network and endosomal sig-
nalling and suggest that C9ORF72 haploinsufficiency may
result in a reduced RRP [2, 19, 53]. Our transcriptomic data
provide further evidence of dysregulated genes associated
with impaired vesicular trans-Golgi network and endoso-
mal signalling in ALS, consistent with a growing body of
evidence of impaired vesicular trafficking in ALS that may
impact on the RRP size [11, 15, 46]. For example, our data
set highlights an upregulation of the GOPC gene, a
chaperone protein that is expressed across the trans-Golgi
network and endosomes. Amongst many interactions,
GOPC is associated with syntaxin-6 that regulates endoso-
mal vesicular transport [7]. Furthermore, TDP-43 protein
appears to bind GOPC RNA [41]. Collectively, our data
show a reduction in the RRP that is consistent with impair-
ments in vesicular trafficking.
Importantly, vesicular release is typically stimulated via
Ca2+-dependent mechanisms. Despite a reduced RRP,
our evaluation of depolarisation/Ca2+-dependent vesicu-
lar release appears to be equivalent in C9ORF72RE exci-
tatory cortical neurons versus isogenic controls. Indeed,
our afterhyperpolarisation (AHP) data suggest that
calcium mediated influx is not impacted to influence
intrinsic excitability properties. However, we must
remain cautious that AHP and exocytosis could be inde-
pendently calcium regulated processes in our cells,
subject to localised intracellular calcium regulation. One
potential explanation could be that localised Ca2+-
dependent mechanisms controlling vesicular release in
C9ORF72RE excitatory cortical neurons are enhanced
over control lines to generate the higher release prob-
ability required to elevate the fold increase in mEPSC
frequency to comparable levels to the control lines. Dys-
regulated cytoplasmic Ca2+ levels in C9ORF72RE-derived
motor neurons have been previously reported [13, 28]
and this elevation in Ca2+ levels may contribute to an in-
creased release probability. However, our findings con-
trast with those of Jensen et al. [28] who suggest that
KCl-stimulated release is impaired, due to a GA-driven
loss of the protein SV2, in C9ORF72RE patient-derived
cortical neurons.
Our data show that synaptic potentiation in
C9ORF72RE excitatory cortical neurons is impaired. Not-
ably, transcranical magnetic stimulation-based studies
show both presymptomatic and post-symptomatic
C9ORF72RE patients exhibit an abolishment of activity-
dependent cortical network plasticity [5]. Together, these
data suggest impairments in functional synaptic plasti-
city may emerge as an early pathophysiological event in
C9ORF72RE–mediated disease progression to impair
network plasticity. The pathological determinants of the
impairments in synaptic plasticity remain unknown in
C9ORF72RE cortical neurons, though a very recent study
has shown synaptic plasticity impairments in murine
C9orf72 knock out animals [27], suggesting a role for the
(See figure on previous page.)
Fig. 3 Synaptic plasticity. a and b Example recordings of mEPSCs prior to and after DPP (10 depolarising pulses of 3 s in duration, every 9 s, from
− 84 to + 16 mV) for C9ORF72RE (1. grey and 2. black, respectively; scale bar; 20 pA, 5 s) and C9ORF72RE-Δ (1. light red and 2. red, respectively; scale
bar; 10 pA, 5 s) neurons. c, d Individual mEPSC amplitude plots for DPP experiments performed upon C9ORF72RE and C9ORF72RE-Δ neurons,
respectively. For C9ORF72RE neurons, mEPSCs before (1) and after DPP (2) are represented in grey and black, respectively. For C9ORF72RE-Δ
neurons, mEPSCs before (1) and after DPP (2) are represented in light red and red, respectively. Note the lack of potentiation in C9ORF72RE, but
not C9ORF72RE-Δ, neurons. e Cumulative probability plots of mEPSC amplitudes for the initial control period (1) and after DPP (2) of the data
shown in C and D. Significance of shift of mEPSC data (Kolmogorov–Smirnov test); C9ORF72RE, p = 0.325; C9ORF72RE-Δ, p < 0.001. f Left, mean
mEPSCs for data shown in B (C9ORF72RE) and C (C9ORF72RE-Δ) for initial control period (1) and post DPP (2). Scale bars; 5 pA, 5 ms. Right, mean
scaled mEPSCs. g Mean ± s.e.m. fold increase of mEPSC amplitude 10 minutes post-DPP from initial control period for control (n = 17), C9–1 (n =
14), C9–1Δ (n = 13), C9–2 (n = 4) and C9–2Δ (n = 10). Example traces and data for the control line are presented in Figure S10. Significance
determined by unpaired t-tests (C9ORF72RE versus C9ORF72RE-Δ) and one-way ANOVA with Bonferroni’s post hoc test (control versus C9ORF72RE )
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Fig. 4 Transcriptomic analysis of C9ORF72RE cortical neurons. a Principal component analysis of gene expression derived from RNA sequencing
from C9ORF72RE cortical neurons (C9–1, C9–2; black) and isogenic gene-corrected control cortical neurons (C9–1Δ, C9–2Δ; red). Each data point
represents a de novo differentiation of cortical neurons. As highlighted, the isogenic controls cluster accordingly with their respective parental
C9ORF72RE lines. b Scatter plot showing comparison of gene expression (as average Fragments Per Kilobase of transcript per Million mapped
reads) from cortical neurons derived from two independent C9ORF72RE iPSC lines and their corresponding isogenic controls. Green and orange
data points denote the overlap of significantly up- and down-regulated genes in both mutant-correction pairs, respectively (false discovery rate,
p < 0.2). c Selected gene ontology terms enriched in dysregulated genes
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C9orf72 protein in plasticity mechanisms. In addition to
our own data set indicating impact upon synaptic physi-
ology, data sets highlight that altered gene expression in
C9ORF72RE patient tissue [46] and disrupted cell signalling
pathways in iPSC-derived C9ORF72RE neurons [13] are im-
plicated in synaptic plasticity. Furthermore, recent tran-
scriptomic work has associated the expression of di-peptide
repeat proteins with a reduction in expression of a mediator
of synaptic plasticity [15]. Our data therefore firmly deter-
mines synaptic plasticity impairments are present in human
C9ORF72RE cortical neurons.
Crucially, C9ORF72RE mutations are causal to both
ALS and FTD. In this regard, we note that the vast
majority of clinical pathophysiological measurements
describing hyperexcitability are made from the motor
cortex, which is primarily affected in ALS [22]. Nonethe-
less cortical hypexcitability is evidenced in rodent
models of FTD [20]. We acknowledge that our data may
have preferential relevance for FTD over ALS, or vice
versa. This is likely to become more apparent with in-
creased pathophysiological characterisation of
C9ORF72RE ALS-FTD patients. Further, early identifica-
tion of pre-symptomatic individuals and longitudinal
stratification of these observations will allow us to place
further confidence upon the pathophysiological staging
that our observations are most likely to mirror. Our data
represent one in vitro time point, but as discussed,
closely align with aspects of pre-symptomatic cortical
neuron impairments evidenced in rodent models of ALS
and ALS-FTD. Importantly, the network excitability is
not investigated in these models. Our data suggest that
increases in synaptic transmission may lead to increased
network burst frequency, however at the same time, in-
dicate that other concurrent processes reduce burst ac-
tivity, reflective of multiple changes in the molecular
landscape of synaptic function, potentially in an attempt
to homeostatically compensate against other network
impairments. Indeed, work performed more extensively
in the context of Alzheimer’s disease has established that
homeostatic network activity adaptation, including im-
paired synaptic plasticity, is an early feature and pre-
cedes that of pathophysiological network failure likely
resulting in the manifestation of the clinically observed
network hyperexcitability [18]. In this regard, there are
intriguing similarities in our data set to cortical neurons
derived from Alzheimer’s patient iPSCs that display in-
creased synaptic activity at the same time point [23].
.
Conclusions
In summary, our study provides physiological evidence
supporting the involvement of widespread glutamatergic
synaptic dysfunction as a potential pathogenic mechan-
ism of C9ORF72RE-mediated disease, a disease that has
considerable impact in cortical neurons in addition to
motor neurons. We reveal that pre and post-synaptic de-
fects are highly prominent in cortical neurons in ALS-
FTD and are suggested to combine to generate early net-
work excitability alterations and impaired synaptic plas-
ticity. We note these are very different physiological
perturbations previously reported for motor neurons de-
rived from C9ORF72RE patients and therefore this study
shows that the pathophysiological processes in different
brain regions are likely to show divergence. These early
synaptic defects are likely linked to core mechanisms of
neurodegenerative disease progression and symptoms in
ALS-FTD.
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Additional file 1: Supplementary Figure 1. Neuronal specification.
Example images of immunostaining against neuronal precursor marker
nestin (A) and human nuclei (B) with neuronal marker βIII-tubulin and
astrocyte marker GFAP. Our cultures at week 5 post-differentiation gener-
ate dense human nuclei-positive neuronal populations (mean ± sem %
human nuclei+ cells with βIII-tubulin; C9–1, 96.8 ± 4.1; C9–1Δ, 97.4 ± 3.0;
C9–2, 90.4 ± 3.2; C9–2Δ, 90.2 ± 4.4; C9–3, 98.5 ± 4.9; C9–3Δ, 96.4 ± 7.1; data
from 3 de novo plate downs) with only negligible detectable levels of
nestin (mean ± sem % nestin; C9–1, 1.1 ± 0.01; C9–1Δ, 2.5 ± 0.1; C9–2,
2.3 ± 0.1; C9–2Δ, 3.5 ± 0.1; C9–3, 1.0 ± 0.1; C9–3Δ, 2.0 ± 0.1; data from 3 de
novo plate downs). Data are consistent with previous cortical neuron dif-
ferentiations with cell lines used in this study and a cortical neuron proto-
col that gives rise to a highly efficient neuronal differentiation [6, 34, 52];.
Scale bars, 100 μm.
Additional file 2: Supplementary Figure 2. A, B and C. Neuronal
specification. RNA-seq analysis of established neuronal and glia markers
(MAPT, NEFL, ALDH1L1, AQ4, MYRF), neuronal markers for anterior/cortical
development (OTX2, PAX6, FOXP4, BCL6), hindbrain development
(HOXB2), cortical layers (CUX1, POU3F2, PCP4, FOXP2), plus glutamatergic
(CAMK2A, SLC17A6 and SLC17A7) and GABA-ergic neurons (GAD2,
SLC32A1, PVALB) in C9 and C9-Δ lines. We note that out analysis ob-
tained extensive detection of cortical transcripts from our cultures and
are consistent with predominantly glutamatergic neurons. Note that the
y axis is presented using a logarithmic scale. Data in C also show synaptic
markers DLG4 and SYN1. Data are representative of mean ± sem from
two pooled C9 lines (black bars) and their respective isogenic lines (red
bars), as further detailed in Fig. 4. Data were derived from 3 plate downs
from each line.
Additional file 3: Supplementary Figure 3. Pharmacological block of
network activity. A, Example whole cell current-clamp recordings of effect
of AMPA receptor blocker, CNQX (30 μM), upon network activity. Scale
bar, 50 mV, 20 s. CNQX generated full block of network burst activity. B,
As in A though for GABAA receptor blocker, bicuculline (30 μM). Scale bar,
50 mV, 5 s. C, Mean (± s.e.m.) percentage shift in burst frequency in pres-
ence of either CNQX or bicuculline for each line type (CNQX – Con, n = 5,
N = 3; C9, n = 5, N = 2; C9-Δ; n = 5, N = 3 / bicuculline – Con, n = 5, N = 3;
C9, n = 5, N = 3; C9-Δ; n = 5, N = 3). Bicuculline did not significantly impact
upon network burst activity. Expectedly, data are consistent with an
enriched population of excitatory glutamatergic cortical neurons [6, 34,
52].
Additional file 4: Supplementary Figure 4. Network burst data. A,
Mean (± s.e.m.) MEA-determined burst duration, interburst length and
spike frequency within the burst for each respective C9ORF72RE and
C9ORF72RE-Δ isogenic pair (C9–1, N = 4; C9–1Δ, N = 6; C9–2, N = 6; C9–2Δ,
N = 3). Significance determined by unpaired t-test. B, Mean (± s.e.m.)
patch-clamp-determined burst duration, interburst length and spike
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frequency within the burst for each respective C9ORF72RE and C9ORF72RE-
Δ isogenic pair (C9–1, n = 8, N = 2; C9–1Δ, n = 8, N = 2; C9–2, n = 8, N = 2;
C9–2Δ, n = 5, N = 2). Significance determined by unpaired t-test.
Additional file 5: Supplementary Figure 5. Intrinsic excitability of
C9ORF72RE-derived cortical neurons. A, Mean (± s.e.m.) data for each
Control- (Con), C9ORF72RE- (C9) and respective C9ORF72RE gene-edited-
(C9-Δ) derived neurons for passive membrane properties (Con, n = 6, N =
2; C9–1, n = 20, N = 3; C9–1Δ, n = 11, N = 3; C9–2, n = 17, N = 3; C9–2Δ,
n = 12, N = 3; C9–3, n = 17, N = 3; C9–3Δ, n = 15, N = 3). The data shows
input resistance (RIN), whole-cell capacitance, resting membrane potential
(RMP). B, Representative whole-cell current-clamp recordings of evoked
responses to current injection (− 20 pA to + 30 pA, 0.5 s duration, 5 pA in-
crements) for a control, C9ORF72RE- and C9ORF72RE neuron. Cells were
held at − 74 mV. Scale bar (40 mV, 100 ms). C, Mean (± s.e.m.) action po-
tential (AP) number-current relationships generated from each paired
C9ORF72RE- and C9ORF72RE gene-edited-derived neurons (C9–1, C9–2, C9–
3) including control data. D, Mean (± s.e.m.) action potential parameters
(threshold, amplitude, and afterhypolarisation, AHP). AP properties were
measured from the first evoked AP of the rheobasic current injection. Sig-
nificance determined by unpaired t-test. We note that we did find slight,
but statistically significant differences for one line in the RMP and AHP
data. However, these are unlikely to be the cause of the altered network
excitability because they are i) extremely modest and ii) not a conserved
finding across all lines.
Additional file 6: Supplementary Figure 6. Synaptic puncta and
neurite length. A, Mean (± s.e.m.) co-localised PSD-95/Synapsin-1 puncta for
each respective C9ORF72RE and C9ORF72RE-Δ isogenic pair (C9–1, N = 4; C9–
1Δ, N = 4; C9–2, N = 4; C9–2Δ, N = 4; C9–3, N = 4; C9–3Δ, N = 4). Significance
determined by unpaired t-test. B. To address neuronal morphology we
transduced cortical NPCs with a low GFP-lentivirus titre in order to be able
to visualise individual neurons. As a measure of morphology, we then mea-
sured the neurite lengths (total sum of all processes) for each cell. C. Data
show the mean ± s.e.m. neurite length (in μm) for each respective
C9ORF72RE and C9ORF72RE-Δ isogenic pair (C9–1, n = 44 cells; C9–1Δ, n = 24;
C9–2, n = 39; C9–2Δ, n = 20; C9–3, n = 17; C9–3Δ, n = 27). All data derived
from 2 de novo preparations. Significance determined by unpaired t-test.
Additional file 7: Supplementary Figure 7. mEPSC amplitude, rise time
and decay properties. A, Cumulative probability plots of mEPSC inter-event
time for each C9ORF72RE- and corresponding C9ORF72RE gene-edited neurons.
Data was obtained from at least 2-min recordings and neurons that displayed
mEPSC frequencies under 0.05 Hz were omitted from the analysis. Significance
of cumulative probability plots determined using Kolmogorov-Smirnov test.
Mean ± s.e.m. mEPSC frequency for each line and respective edit are shown
inset (C9–1, n= 23, N= 5; C9–1Δ, n= 15, N= 4; C9–2, n= 17, N= 4; C9–2Δ,
n= 11, N= 3; C9–3, n= 12, N= 3; C9–3Δ, n= 16, N= 4). B, As A though for
mEPSC amplitude. C, Mean ± s.e.m. mEPSC rise time (10–90%) and τ decay
properties for each line (C9–1, n = 15, N= 4; C9–1Δ, n= 12, N= 3; C9–2, n= 12,
N= 3; C9–2Δ, n= 5, N= 2; C9–3, n= 8, N = 3; C9–3Δ, n= 13, N= 3). Signifi-
cance determined by Welch’s t-test or unpaired t-test. Other than mEPSC fre-
quency (Fig. 2), data are not consistent with altered mEPSC properties. We
note that we did find slight, but statistically significant differences for one line
in the mEPSC amplitude and rise time data. However, these are unlikely to be
the cause of altered network excitability observed in our cultures because they
are i) extremely modest and ii) not a conserved finding across all lines. D.
RNA-seq analysis of AMPA receptor subunits (GRIA1–4) in C9 and C9-Δ lines.
Note that the y axis is presented using a logarithmic scale. Data are represen-
tative of mean ± sem from two pooled C9 lines (black bars) and their respect-
ive isogenic lines (red bars), as detailed in Fig. 4. Data were derived from 3
plate downs from each line. The data are not consistent with any change in
expression between C9 and C9-Δ lines.
Additional file 8: Supplementary Figure 8. mEPSC amplitude in the
presence and absence of hypertonic sucrose. A, Representative recording
of mEPSC activity before (baseline) and in the presence of sucrose (0.5 M,
filled bar). The initial transient and steady-state phases of the sucrose-
evoked response are highlighted. Scale bars; 50 pA, 5 s. B, Mean ± s.e.m.
fold change in mEPSC frequency for each line for the transient (C9–1,
n = 9, N = 3; C9–1Δ, n = 10, N = 3; C9–2, n = 8, N = 3; C9–2Δ, n = 6, N = 2;
C9–3, n = 11, N = 4; C9–3Δ, n = 14, N = 4) and steady state phases (C9–1,
n = 7, N = 2; C9–1Δ, n = 6, N = 3; C9–2, n = 8, N = 3; C9–2Δ, n = 6, N = 2;
C9–3, n = 8, N = 3; C9–3Δ, n = 11, N = 3). C, As in B, though for mEPSC
amplitude for the transient (C9–1, n = 7; C9–1Δ, n = 6; C9–2, n = 8; C9–
2Δ, n = 6; C9–3, n = 10, N = 3; C9–3Δ, n = 12, N = 3) and steady-state
phases (C9–1, n = 7; C9–1Δ, n = 6; C9–2, n = 8; C9–2Δ, n = 6; C9–3, n = 7,
N = 3; C9–3Δ, n = 11, N = 3). Significance determined by two-tailed un-
paired t-test. The patch pipette solution was supplemented with BAPTA
(1 mM) to prevent potential Ca2+-dependent modulation of post-synaptic
neuron properties.
Additional file 9: Supplementary Figure 9. KCl-evoked release prop-
erties. A, Sample traces from recordings of mEPSC events before and in
the presence of KCl (30 mM) from C9ORF72RE- and C9ORF72RE-Δ-cortical
neurons (C9–2 and C9–2Δ). Scale bars; 50 pA, 5 s. B, Mean ± s.e.m. fold
change in mEPSC frequency for each line in the presence of KCl (C9–1,
n = 5, N = 2; C9–1Δ, n = 5, N = 2; C9–2, n = 3, N = 2; C9–2Δ, n = 3, N = 2;
C9–3, N = 2, n = 7, C9–3Δ, n = 5, N = 2). No statistical difference between
each C9ORF72RE and C9ORF72RE-Δ pair was determined (unpaired t-test).
mEPSC frequency in the presence of KCl was determined from a stretch
of recording at least 1 min in duration. The patch pipette solution was
supplemented with BAPTA (1 mM) to prevent potential Ca2+-dependent
modulation of post-synaptic neuron properties.
Additional file 10: Supplementary Figure 10. Depolarisation-
mediated mEPSC amplitude potentiation. A. Example recordings of
mEPSCs prior (1. light blue) to and after (2. blue) the depolarisation pulse
protocol (DPP, 10 depolarising pulses of 3 s in duration, every 9 s, from −
84 to + 16 mV). Example post-DPP mEPSCs are sampled from the 8–10
min stretch of data. Scale bar; 10 pA, 2.5 s. B. Individual mEPSC amplitude
plot in an example experiment. mEPSCs before (1) and after DPP (2) are
represented in light blue and blue, respectively. The grey bar indicates the
stimulation period. Note the transient increase in mEPSC amplitude post-
DPP. C. Cumulative probability plot showing a shift (p < 0.001, Kolmogo-
rov–Smirnov test) in mEPSC amplitude data in B from the initial control
period (1. light blue) to the 10 min post-DPP period (2. blue) in which
there is consistent, transient potentiation of mEPSC amplitude. D. Left,
mean mEPSCs for data shown in B for initial control period (1. light blue)
and 10 min post-DPP (2. blue). Scale bar; 5 pA, 5 ms. Right, mean mEPSCs
scaled to amplitude and time base. E. To test whether potentiation was
Ca2+-dependent we performed DPP in the presence of nifedipine, a
blocker of voltage-gated Ca2+ channels, or BAPTA, a Ca2+ chelator, sup-
plemented to the patch pipette. Data shows mean ± s.e.m. fold increase
of mEPSC amplitude 10 min post-DPP from initial control period for the
control line (n = 17), + nifedipine (n = 14) and + BAPTA (n = 6). Example
traces and data presented in Supplementary Figure 11. Significance deter-
mined by one-way ANOVA with Bonferroni’s post hoc test.
Additional file 11: Supplementary Figure 11. Ca2+-dependent
mEPSC potentiation. A. Example recordings of mEPSCs prior to (1. light
blue) and after (2. blue) depolarisation in the presence of nifedipine
(10 μM, applied to the extracellular solution). Scale bar; 20 pA, 2.5 s. B.
Individual mEPSC amplitude plots for DPP experiments in the presence
of nifedipine. mEPSCs before (1) and after DPP (2) are represented in light
blue and blue, respectively. C. Cumulative probability plot of mEPSC
amplitudes for the initial control period (1. light blue) and after DPP (2.
blue) in the presence of nifedipine of the data shown in B. Whilst shift in
mEPSC amplitude in the presence of nifedipine is significant (p < 0.01,
Kolmogorov–Smirnov test), the shift is a decrease in mEPSC amplitude. D.
As in A though in the presence of BAPTA (10 mM, to the intracellular
solution). E. As in B though in the presence of BAPTA. F. Cumulative
probability plot of mEPSC amplitudes for the initial control period (1. light
blue) and after DPP (2. blue) in the presence of BAPTA for the data shown
in E. Shift in mESPC amplitude is not significant (p = 0.937, Kolmogorov–
Smirnov test). G. The fold change in mEPSC decay time constant post-
DPP with respect to baseline activity (Con, n = 5; C9, n = 5; C9-Δ, n = 5).
Fold changes are not significant (one-way ANOVA with Bonferroni’s mul-
tiple comparisons test). Data are consistent with the fact that average
scaled mEPSC traces from pre- and post-DPP stages are superimposable.
Additional file 12.
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